ExodusPoint Capital Management’s Establishment Labs ESTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.49M Sell
79,027
-46,725
-37% -$3.19M 0.04% 476
2025
Q4
$9.16M Buy
+125,752
New +$7.59M 0.07% 283
2025
Q3
Sell
-37,596
Closed -$1.61M 1676
2025
Q2
$1.61M Buy
37,596
+28,908
+333% +$1.01M 0.01% 818
2025
Q1
$355K Buy
+8,688
New +$324K ﹤0.01% 1197
2024
Q3
Sell
-107,952
Closed -$4.91M 1749
2024
Q2
$4.91M Buy
+107,952
New +$5.48M 0.03% 413
2022
Q4
Sell
-5,453
Closed -$298K 1765
2022
Q3
$298K Buy
+5,453
New +$326K ﹤0.01% 1526
2022
Q2
Sell
-3,410
Closed -$230K 2069
2022
Q1
$230K Sell
3,410
-27
-0.8% -$1.58K ﹤0.01% 1851
2021
Q4
$232K Buy
+3,437
New +$240K ﹤0.01% 1763
2020
Q2
Sell
-51,323
Closed -$742K 1834
2020
Q1
$742K Buy
51,323
+40,037
+355% +$884K 0.04% 368
2019
Q4
$312K Buy
+11,286
New +$250K 0.01% 1131

Other funds holding ESTA

ExodusPoint Capital Management's ESTA Position: Q1 2026 in Review

ExodusPoint Capital Management reduced its Establishment Labs (ESTA) stake by 37% in Q1 2026, selling an estimated $3.19M and leaving 79,027 shares worth $4.49M. The position accounts for 0.04% of the portfolio, ranked #476.

ExodusPoint Capital Management first reported a position in ESTA in Q4 2019 and has held it in 10 quarters since. The position peaked at $9.16M in Q4 2025. 176 funds tracked by Wall St. Rank hold ESTA as of Q1 2026.

  • ExodusPoint Capital Management held 79,027 shares of Establishment Labs worth $4.49M as of Q1 2026.
  • ExodusPoint Capital Management sold 46,725 Establishment Labs shares in Q1 2026, an estimated $3.19M.
  • Establishment Labs made up 0.04% of ExodusPoint Capital Management's portfolio in Q1 2026, its #476 holding.
  • ExodusPoint Capital Management first reported a position in Establishment Labs in Q4 2019 and has held it in 10 quarters since.
  • ExodusPoint Capital Management's Establishment Labs position peaked at $9.16M in Q4 2025.
  • 176 funds tracked by Wall St. Rank held Establishment Labs as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.